Cajal Therapeutics
Advancing medicines to restore homeostasis
Seattle, United States · Founded 2020
- Headquarters
- Seattle, Washington
- Founded
- 2020
- Business Model
- B2B
- Website
- cajal-tx.com
About
Cajal Therapeutics is developing novel medicines for serious diseases, including anemias of inflammation, neurodegenerative diseases, and other iron-related disorders. The company is advancing small molecule and RNA medicines that restore iron homeostasis across systemic and neurologic diseases. Its lead program, CTX001, is a first-in-class iron mobilizer designed to restore iron transport and make iron available again to key metabolic and cellular processes.
Summary
Cajal Therapeutics is a Biotech company based in Seattle, United States, founded in 2020.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cajal-therapeutics"><img src="https://indexed.vc/api/badge/company/cajal-therapeutics" alt="Cajal Therapeutics on Indexed.vc" width="260" height="76" /></a>